| Identification | Back Directory | [Name]
Plonmarlimab | [CAS]
2377482-36-3 | [Synonyms]
Plonmarlimab
Plonmarlimab (anti-GM-CSF)
Research Grade Plonmarlimab
Research Grade Plonmarlimab (DHC06705) |
| Hazard Information | Back Directory | [Uses]
Plonmarlimab (TJ003234) is an anti-GM-CSF monoclonal antibody. Plonmarlimab can be used for research of rheumatoid arthritis and COVID-19[1][2]. | [References]
[1] Bonaventura A, et al. Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies. Front Immunol. 2020 Jul 3;11:1625. DOI:10.3389/fimmu.2020.01625
[2] Bonam SR, et al. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients. Cell Rep Med. 2020 May 19;1(2):100016. DOI:10.1016/j.xcrm.2020.100016 |
|
| Company Name: |
Biolab Reagents
|
| Tel: |
65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
| Company Name: |
Cell Sciences
|
| Tel: |
9785721070 |
| Website: |
www.cellsciences.com |
|